| Literature DB >> 28208794 |
Chrysostomi Zisi1, Ioannis Sampsonidis2, Stella Fasoula3, Konstantinos Papachristos4, Michael Witting5, Helen G Gika6, Panagiotis Nikitas7, Adriani Pappa-Louisi8.
Abstract
Modified quantitative structure retention relationships (QSRRs) are proposed and applied to describe two retention data sets: A set of 94 metabolites studied by a hydrophilic interaction chromatography system under organic content gradient conditions and a set of tryptophan and its major metabolites analyzed by a reversed-phase chromatographic system under isocratic as well as pH and/or simultaneous pH and organic content gradient conditions. According to the proposed modification, an additional descriptor is added to a conventional QSRR expression, which is the analyte retention time, tR(R), measured under the same elution conditions, but in a second chromatographic column considered as a reference one. The 94 metabolites were studied on an Amide column using a Bare Silica column as a reference. For the second dataset, a Kinetex EVO C18 and a Gemini-NX column were used, where each of them was served as a reference column of the other. We found in all cases a significant improvement of the performance of the QSRR models when the descriptor tR(R) was considered.Entities:
Keywords: HPLC retention; metabolites identification; quantitative structure retention relationship models
Year: 2017 PMID: 28208794 PMCID: PMC5372210 DOI: 10.3390/metabo7010007
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
QSRR models describing the retention of 94 metabolite standards for each chromatographic based on Equation (2).
| MDs (Amide) | Adjustable Parameters (Amide) | MDs (Bare Silica) | Adjustable Parameters (Bare Silica) |
|---|---|---|---|
| tpsaEfficiency | 9.64 ± 0.85 | tpsaEfficiency | 8.02 ± 0.88 |
| XLogP | −0.84 ± 0.14 | nA | 3.73 ± 0.57 |
| nBase | 3.37 ± 0.42 | nHBAcc | 0.35 ± 0.10 |
| MDEC.33 | 0.25 ± 0.08 | fr_C_O_noCOO | 1.48 ± 0.31 |
| nR | −8.77 ± 2.64 | fr_NH1 | −1.49 ± 0.50 |
| C2SP3 | 0.24 ± 0.10 | khs.sNH2 | 1.02 ± 0.41 |
1 Average absolute difference of experimental and calculated tR/Maximum absolute difference of experimental and calculated tR/Standard error of the estimate SEE.
QSRR model describing the retention of 94 metabolite standards for the Amide column based on Equation (1) and using their retention data on the Bare Silica column as a reference column.
| MDs/tR(R) | Adjustable Parameters |
|---|---|
| tpsaEfficiency | 5.62 ± 0.81 |
| XLogP | −0.53 ± 0.11 |
| nBase | 0.67 ± 0.46 |
| MDEC.33 | 0.24 ± 0.60 |
| nR | −1.49 ± 2.19 |
| C2SP3 | 0.03 ± 0.08 |
| tR(R) | 0.60 ± 0.07 |
1 Average absolute difference of experimental and calculated tR/Maximum absolute difference of experimental and calculated tR/Standard error of the estimate SEE.
QSRR models describing the retention of each of four groups of chemically related compounds for Amide column based on Equations (1) and (2), where in Equation (1) the Bare Silica column is used as a reference column.
| Metabolites Chemical Group | MDs | Adjustable Parameters of Equation (2) | MDs/tR(R) | Adjustable Parameters of Equation (1) |
|---|---|---|---|---|
| Sugars | tpsaEfficiency | 13.07 ± 0.91 | tpsaEfficiency | 13.51 ± 0.94 |
| nHBAcc | 0.53 ± 0.06 | nHBAcc | 0.24 ± 0.23 | |
| tR(R) | 0.36 ± 0.17 | |||
| Amino acids | tpsaEfficiency | 6.86 ± 1.79 | tpsaEfficiency | 2.63 ± 0.47 |
| MinPartialCharge | −13.36 ± 1.87 | MinPartialCharge | 0.72 ± 0.77 | |
| nHBAcc | 0.76 ± 0.21 | nHBAcc | 0.11 ± 0.06 | |
| tR(R) | 0.95 ± 0.04 | |||
| MDEC.33 | 0.80 ± 0.25 | MDEC.33 | 0.39 ± 0.10 | |
| XLogP | −1.76 ± 0.33 | XLogP | −0.42 ± 0.17 | |
| khs.sNH2 | 5.47 ± 1.42 | khs.sNH2 | 0.26 ± 0.70 | |
| nHBAcc | 0.88 ± 0.26 | nHBAcc | −0.33 ± 0.15 | |
| tR(R) | 1.50 ± 0.10 | |||
| Nucleonic bases-nucleosides | tpsaEfficiency | 14.93 ± 1.21 | tpsaEfficiency | 7.24 ± 3.9 |
| tR(R) | 0.92 ± 0.45 | |||
1 Average absolute difference of experimental and calculated tR/Maximum absolute difference of experimental and calculated tR/Standard error of the estimate SEE.
QSRR models, based on Equation (2), describing the retention of tryptophan and its major metabolites for each chromatographic column.
| Three-Parameter QSRR Model | ||||||||
|---|---|---|---|---|---|---|---|---|
| EVO | Gemini | |||||||
| MDs | G1 | G2 | G3 | G4 | G1 | G2 | G3 | G4 |
| pKa1 | −0.82 ± 0.30 | −0.60 ± 0.32 | −0.61 ± 0.24 | −0.41 ± 0.50 | −1.08 ± 0.30 | −0.74 ± 0.37 | −0.71 ± 0.15 | −0.56 ± 0.65 |
| pKa2 | 1.17 ± 0.13 | 0.86 ± 0.14 | 1.01 ± 0.11 | 0.73 ± 0.22 | 1.52 ± 0.13 | 1.09 ± 0.18 | 1.27 ± 0.07 | 0.93 ± 0.29 |
| logP | 2.30 ± 0.57 | 1.96 ± 0.62 | 1.63 ± 0.47 | 2.36 ± 0.96 | 2.91 ± 0.58 | 2.04 ± 0.76 | 2.24 ± 0.29 | 2.22 ± 1.05 |
1 Average absolute difference of experimental and calculated tR/Maximum absolute difference of experimental and calculated tR/Standard error of the estimate SEE.
QSRR models, based on Equation (1), describing the retention of tryptophan and its major metabolites for each chromatographic column using the other column as a reference one.
| Three-Parameter QSRR Model | ||||||||
|---|---|---|---|---|---|---|---|---|
| EVO | Gemini | |||||||
| MDs/tR(R) | G1 | G2 | G3 | G4 | G1 | G2 | G3 | G4 |
| pKa1 | 0.15 ± 0.27 | −0.07 ± 0.21 | 0.42 ± 0.28 | −0.03 ± 0.26 | −0.33 ± 0.23 | −0.08 ± 0.26 | −0.37 ± 0.11 | −0.08 ± 0.34 |
| pKa2 | −0.20 ± 0.33 | 0.08 ± 0.21 | −0.82 ± 0.45 | 0.08 ± 0.19 | 0.46 ± 0.26 | 0.13 ± 0.26 | 0.70 ± 0.14 | 0.08 ± 0.25 |
| logP | −0.31 ± 0.68 | 0.50 ± 0.49 | −1.61 ± 0.82 | 0.82 ± 0.60 | 0.82 ± 0.57 | −0.13 ± 0.68 | 1.33 ± 0.26 | −0.54 ± 0.91 |
| tR(R) | 0.90 ± 0.21 | 0.72 ± 0.18 | 1.44 ± 0.35 | 0.69 ± 0.17 | 0.91 ± 0.22 | 1.11 ± 0.28 | 0.56 ± 0.14 | 1.17 ± 0.28 |
1 Average absolute difference of experimental and calculated tR/Maximum absolute difference of experimental and calculated tR/Standard error of the estimate SEE.